Combined Holdings of Schrödinger, Inc. (SDGR) - Updated Daily
Software As A ServiceBioinformaticsGenomics
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 0.73% | $1.79b |
| 🏋️♀️Weight Rank Across All Funds | 🌏Country |
| 27 | 🇺🇸United States |
| 💳ARK Estimated Cost Average | 🎫ARK Ownership Percent |
$57.16 - ARKG | 6.1% |
| Description | |
|---|---|
| Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger's multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs. | |
| Website | |
| www.schrodinger.com |
Other ETFs That Hold SDGR
Research Notes and Commentary for SDGR
August 12, 2021
August 11-12, 2021: ARK Trades and Storylines
Trading Floor
March 12, 2021
SDGR Hiring vs Stock Price
Trading Floor